BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20816088)

  • 1. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.
    Kjolby M; Andersen OM; Breiderhoff T; Fjorback AW; Pedersen KM; Madsen P; Jansen P; Heeren J; Willnow TE; Nykjaer A
    Cell Metab; 2010 Sep; 12(3):213-23. PubMed ID: 20816088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association studies identify new targets in cardiovascular disease.
    Calkin AC; Tontonoz P
    Sci Transl Med; 2010 Sep; 2(48):48ps46. PubMed ID: 20826839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sortilin and the risk of cardiovascular disease.
    Coutinho MF; Bourbon M; Prata MJ; Alves S
    Rev Port Cardiol; 2013 Oct; 32(10):793-9. PubMed ID: 23910371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100.
    Amengual J; Guo L; Strong A; Madrigal-Matute J; Wang H; Kaushik S; Brodsky JL; Rader DJ; Cuervo AM; Fisher EA
    Circ Res; 2018 Feb; 122(4):568-582. PubMed ID: 29301854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.
    Strong A; Ding Q; Edmondson AC; Millar JS; Sachs KV; Li X; Kumaravel A; Wang MY; Ai D; Guo L; Alexander ET; Nguyen D; Lund-Katz S; Phillips MC; Morales CR; Tall AR; Kathiresan S; Fisher EA; Musunuru K; Rader DJ
    J Clin Invest; 2012 Aug; 122(8):2807-16. PubMed ID: 22751103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sortilin: an unusual suspect in cholesterol metabolism: from GWAS identification to in vivo biochemical analyses, sortilin has been identified as a novel mediator of human lipoprotein metabolism.
    Dubé JB; Johansen CT; Hegele RA
    Bioessays; 2011 Jun; 33(6):430-7. PubMed ID: 21462369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sortilin, encoded by the cardiovascular risk gene SORT1, and its suggested functions in cardiovascular disease.
    Kjolby M; Nielsen MS; Petersen CM
    Curr Atheroscler Rep; 2015 Apr; 17(4):496. PubMed ID: 25702058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.
    Musunuru K; Strong A; Frank-Kamenetsky M; Lee NE; Ahfeldt T; Sachs KV; Li X; Li H; Kuperwasser N; Ruda VM; Pirruccello JP; Muchmore B; Prokunina-Olsson L; Hall JL; Schadt EE; Morales CR; Lund-Katz S; Phillips MC; Wong J; Cantley W; Racie T; Ejebe KG; Orho-Melander M; Melander O; Koteliansky V; Fitzgerald K; Krauss RM; Cowan CA; Kathiresan S; Rader DJ
    Nature; 2010 Aug; 466(7307):714-9. PubMed ID: 20686566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis.
    Zhang T; Shi H; Liu N; Tian J; Zhao X; Steer CJ; Han Q; Song G
    Theranostics; 2020; 10(9):3952-3966. PubMed ID: 32226531
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sortilin and lipoprotein metabolism: making sense out of complexity.
    Strong A; Patel K; Rader DJ
    Curr Opin Lipidol; 2014 Oct; 25(5):350-7. PubMed ID: 25101658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
    Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
    J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia.
    Tveten K; Strøm TB; Cameron J; Berge KE; Leren TP
    Atherosclerosis; 2012 Dec; 225(2):370-5. PubMed ID: 23102784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense variants in SORT1 are associated with LDL-C in an Amish population.
    Mitok KA; Schueler KL; King SM; Orr J; Ryan KA; Keller MP; Krauss RM; Mitchell BD; Shuldiner AR; Attie AD
    J Lipid Res; 2023 Dec; 64(12):100468. PubMed ID: 37913995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion.
    Gustafsen C; Kjolby M; Nyegaard M; Mattheisen M; Lundhede J; Buttenschøn H; Mors O; Bentzon JF; Madsen P; Nykjaer A; Glerup S
    Cell Metab; 2014 Feb; 19(2):310-8. PubMed ID: 24506872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density lipoprotein (LDL)-mediated suppression of Lewis lung carcinoma in hypercholesterolemic LDL receptor-deficient mice.
    Trieu VN; Uckun FM
    Biochem Biophys Res Commun; 1999 Feb; 255(2):377-81. PubMed ID: 10049716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.
    Linsel-Nitschke P; Heeren J; Aherrahrou Z; Bruse P; Gieger C; Illig T; Prokisch H; Heim K; Doering A; Peters A; Meitinger T; Wichmann HE; Hinney A; Reinehr T; Roth C; Ortlepp JR; Soufi M; Sattler AM; Schaefer J; Stark K; Hengstenberg C; Schaefer A; Schreiber S; Kronenberg F; Samani NJ; Schunkert H; Erdmann J
    Atherosclerosis; 2010 Jan; 208(1):183-9. PubMed ID: 19660754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance induces posttranslational hepatic sortilin 1 degradation in mice.
    Li J; Matye DJ; Li T
    J Biol Chem; 2015 May; 290(18):11526-36. PubMed ID: 25805502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.